Intuitive Surgical 株価情報 (NASDAQ: ISRG)

Intuitive Surgical (NASDAQ:ISRG) 株価情報

INTUITIVE SURGICAL INC

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ISRG

NFLX

アメリカの株先物は金曜日の朝、低い動きを見せており、投資家の動きも慎重になっている。ウォール街は、オープニングベルの前に、The Procter &amp; Gamble Company（NYSE:PG）が1株あたり1.41ドル、225.41億ドルの売上で四半期決算を発表すると見込んでいます。これはBenzinga Proのデータより明らかになっています。Procter &amp; Gambleの株は、アフターセッションで157.14ドルに0.1％の下落となった。Intuitive Surgical Inc（NASDAQ:ISRG）は、木曜日に第1四半期の決算を予想を上回る結果を発表しました。インチュイティブ・サージカルの株はアフターセッションで3.5％上昇し、385.60ドルで取引されている。アナリストは、American Express Company（NYSE:AXP）が純利益2.95ドル、157.9億ドルの売上で四半期決算を発表すると予想しています。同社は市場がオープンする前に決算を発表します。アメリカン・エキスプレスの株はアフターセッションで、213.90ドルに1.7％下落を記録した。こちらのプレマーケットのカバレッジをチェックNetflix Inc（NASDAQ:NFLX）は第1四半期の楽観的な決算と売上の結果を発表しました。同社は第1四半期に933万人の有料会員を追加し、合計2億6960万人の会員数になりました。Netflixの株はアフターセッションで4.8％下落し、581.49ドルで取引されている。アナリストは、Schlumberger Limited（NYSE:SLB）がオープニングベルの前に1株あたり75セントの四半期利益を、86.9億ドルの売上で発表すると予想しています。SLBの株はアフターセッションで0.5％下落し、50.69ドルで取引されている。

「Netflix（ネットフリックス）、Procter＆Gamble（プロクター＆ギャンブル）」金曜日に注目すべき株式

Intuitive Surgical Inc

Deep-pocketed investors have adopted a bullish approach towards Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ISRG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Intuitive Surgical. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 66% leaning bullish and 33% bearish. Among these notable options, 4 are puts, totaling $656,966, and 5 are calls, amounting to $153,837.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $395.0 to $530.0 for Intuitive Surgical over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 207.0 with a total volume of 1,433.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $395.0 to $530.0 over the last 30 days.
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689153_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$7.1</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$480.00</td>
<td>$521.3K</td>
<td align="right">287</td>
<td align="right">747</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$4.9</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$395.00</td>
<td>$53.2K</td>
<td align="right">3</td>
<td align="right">111</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$33.7</td>
<td>$30.9</td>
<td>$33.7</td>
<td>$525.00</td>
<td>$47.1K</td>
<td align="right">96</td>
<td align="right">14</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$31.3</td>
<td>$28.0</td>
<td>$30.16</td>
<td>$500.00</td>
<td>$36.1K</td>
<td align="right">225</td>
<td align="right">20</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/04/25</td>
<td>$38.0</td>
<td>$35.1</td>
<td>$35.1</td>
<td>$530.00</td>
<td>$35.1K</td>
<td align="right">17</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
Following our analysis of the options activities associated with Intuitive Surgical, we pivot to a closer look at the company's own performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>Currently trading with a volume of 241,332, the ISRG's price is down by -2.2%, now at $495.88. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 19 days.</li>
</ul>
<h3>Professional Analyst Ratings for Intuitive Surgical</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $602.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Baird persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $600. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $605. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Surgical options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

What the Options Market Tells Us About Intuitive Surgical

Intuitive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced the publication of two peer-reviewed studies in Surgical Endoscopy, on its first-of-its-kind Force Feedback technology incorporated in the da Vinci 5 surgical system.&nbsp;&nbsp;
Force Feedback technology allows surgeons to feel the forces applied to tissue during surgery, such as pushing and pulling. These studies - conducted in the pre-clinical setting using tissue models - demonstrate its potential to reduce the amount of force placed on tissue during surgery and enhance surgeon performance.
The first study, led by a team including Michael M. Awad MD, PhD, Professor of Surgery at Washington University School of Medicine in St. Louis, showed that using Force Feedback technology can lead to a reduction in force on tissue by up to 43 percent, irrespective of the surgeon's experience level. The study evaluated the forces applied to surgical models by 28 surgeons who had varying levels of experience when using Force Feedback technology during retraction, dissection, and suturing tasks.

Biotech

General

Intuitive Announces The Publication Of Two Peer-Reviewed Studies In Surgical Endoscopy, On Its Force Feedback Technology Incorporated In The Da Vinci 5 Surgical System

Deep-pocketed investors have adopted a bullish approach towards Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ISRG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Intuitive Surgical. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 11% bearish. Among these notable options, 3 are puts, totaling $101,684, and 6 are calls, amounting to $234,587.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $420.0 to $550.0 for Intuitive Surgical during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale trades within a strike price range from $420.0 to $550.0 in the last 30 days. 
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743009333_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$44.1</td>
<td>$41.7</td>
<td>$42.86</td>
<td>$530.00</td>
<td>$85.9K</td>
<td align="right">117</td>
<td align="right">20</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$34.8</td>
<td>$34.1</td>
<td>$34.8</td>
<td>$485.00</td>
<td>$38.2K</td>
<td align="right">62</td>
<td align="right">11</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$19.5</td>
<td>$17.1</td>
<td>$18.12</td>
<td>$520.00</td>
<td>$36.2K</td>
<td align="right">154</td>
<td align="right">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$48.4</td>
<td>$46.6</td>
<td>$47.6</td>
<td>$500.00</td>
<td>$33.3K</td>
<td align="right">355</td>
<td align="right">12</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$29.9</td>
<td>$29.2</td>
<td>$29.2</td>
<td>$520.00</td>
<td>$32.1K</td>
<td align="right">126</td>
<td align="right">12</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
In light of the recent options history for Intuitive Surgical, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Intuitive Surgical Standing Right Now?</h3>
<ul>
<li>With a volume of 939,608, the price of ISRG is down -2.07% at $509.05. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 27 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuitive Surgical</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $602.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Intuitive Surgical with a target price of $605. 
&#x2A; An analyst from Baird persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $600. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuitive Surgical, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 5 years by 9.33% on an annualized basis producing an average annual return of 27.47%. Currently, Intuitive Surgical has a market capitalization of $173.59 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 5 years ago, it would be worth $395.27 today based on a price of $484.53 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742568308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 10%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $578,750, and 3 are calls, for a total amount of $332,362.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $430.0 to $560.0 for Intuitive Surgical over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Intuitive Surgical's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Intuitive Surgical's substantial trades, within a strike price spectrum from $430.0 to $560.0 over the preceding 30 days.
<h3>Intuitive Surgical Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742311859_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$38.2</td>
<td>$37.1</td>
<td>$37.1</td>
<td>$485.00</td>
<td>$278.2K</td>
<td align="right">15</td>
<td align="right">75</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$47.5</td>
<td>$46.1</td>
<td>$46.78</td>
<td>$490.00</td>
<td>$187.2K</td>
<td align="right">23</td>
<td align="right">40</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$16.2</td>
<td>$16.1</td>
<td>$16.1</td>
<td>$440.00</td>
<td>$94.9K</td>
<td align="right">251</td>
<td align="right">61</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$47.2</td>
<td>$46.3</td>
<td>$47.2</td>
<td>$490.00</td>
<td>$94.4K</td>
<td align="right">23</td>
<td align="right">40</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$68.2</td>
<td>$66.5</td>
<td>$68.2</td>
<td>$550.00</td>
<td>$68.2K</td>
<td align="right">18</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>Trading volume stands at 376,046, with ISRG's price down by -1.73%, positioned at $480.33.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Expert Opinions on Intuitive Surgical</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $602.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Intuitive Surgical, which currently sits at a price target of $600. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Intuitive Surgical, targeting a price of $605. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Surgical options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

This Is What Whales Are Betting On Intuitive Surgical

Baird analyst David Rescott maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and lowers the price target from $707 to $600.

Price Target

Analyst Ratings

Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $600

Truist Securities analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and lowers the price target from $666 to $605.

Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $605

Last week,&nbsp;U.S. President&nbsp;Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on&nbsp;<a target="_blank" href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market" rel="noreferrer noopener">those from China to 20%</a>.
China responded to Trump&#8217;s recent tariff hikes by placing its own tariffs on certain U.S. goods, sanctioning American companies, and planning to file a complaint with&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/25/03/44117288/after-china-mexico-to-hit-back-against-trumps-tariffs-raising-trade-war-risks" rel="noreferrer noopener">the World Trade Organization</a>.
China also banned imports of <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">genetic sequencers</a> from&nbsp;Illumina Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43706143/why-is-ge-healthcare-stock-trading-higher-on-thursday" rel="noreferrer noopener">Why Is GE HealthCare Stock Trading Soaring On Thursday?</a>
Goldman Sachs has grown more confident that end markets are stabilizing and set for a recovery in 2025, despite ongoing policy and tariff uncertainties. Rising demand and increased stimulus are helping ease market bottlenecks.
Following a visit to China, Goldman Sachs analysts see capital equipment markets at a turning point and write that innovation remains a key advantage.
They are also optimistic about GE Healthcare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) and Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) in the region.
While Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) offers unique technology, economic constraints, and national quotas may limit its growth. Meanwhile, local competition is expanding quickly, but Goldman Sachs sees limited impact due to a lack of technological differentiation. As a result, analyst David Roman upgraded GE Healthcare stock from Neutral to Buy, raising the <a target="_blank" href="https://editorial.benzinga.com/wp-admin/post.php?post=819159&amp;action=edit" rel="noreferrer noopener">price target from $85 to $100</a>.
The analyst has a balanced view on GE Healthcare with stable 4-5% growth in the base business (ex-China), offset by sustained headwinds in the China business (~14% of sales), which would yield top-line growth below consensus and the company&#8217;s medium targets of 4-6% organic revenue growth.
The forecast increase is due to stabilizing trends in China. The analyst expects China sales to return to 2023 levels by 2026, unlike the previous forecast, which did not anticipate a rebound through 2028.
Price Action: GEHC stock is up 0.45% at $85.74&nbsp;at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44251506/inuvo-is-better-aligned-with-consumer-demand-for-privacy-new-regulations-analyst" target="_blank" rel="noreferrer noopener">Inuvo Is Better Aligned With Consumer Demand For Privacy, New Regulations: Analyst</a></li>
</ul>
Photo by PixelBiss via Shutterstock

Analyst Color

Large Cap

Upgrades

Health Care

GEHC

ILMN

Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) will join the S&amp;P 100 index, S&amp;P Dow Jones Indices announced Friday, as the data analytics firm continues its remarkable post-election rally.
What Happened: &#8220;Palantir is proud to be admitted into the S&amp;P 100. Onwards,&#8221; the company stated Sunday on X.
The Denver-based company will replace Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) in the index effective Mar. 24, coinciding with the quarterly rebalance. Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) and ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) will also join the S&amp;P 100, replacing The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>).
Palantir has emerged as the top-performing S&amp;P 500 stock since President Donald Trump&#8216;s November election victory, surging nearly 60% to $84.82. This represents an annualized return exceeding 184%, <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win">according to Benzinga Pro data</a>.
Market analysts attribute Palantir&#8217;s meteoric rise to its artificial intelligence capabilities and CEO Alex Karp&#8216;s support for <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win">government efficiency initiatives</a>. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Palantir is proud to be admitted into the S&amp;P 100. Onwards. <a href="https://t.co/WxwfObpIUG">pic.twitter.com/WxwfObpIUG</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1898888631944630768?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44212386/stock-futures-drop-as-reverse-trump-trade-takes-holdpeter-schiff-says-market-shift-long-overdue-and-will-likely-continue-for-a-decade">Stock Futures Drop As &#8216;Reverse Trump Trade&#8217; Takes Hold—Peter Schiff Says Market Shift &#8216;Long Overdue&#8217; And Will Likely Continue For A Decade</a>
Why It Matters: Recent analyst assessments present a mixed outlook. While the <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">consensus price target</a> stands at $70.30 among 25 analysts, the three most recent ratings from Wedbush, Loop Capital, and Citigroup average $123.67, implying a potential upside of nearly 46%.
Other significant S&amp;P index changes announced include DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) joining the S&amp;P 500, while FMC Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) and Celanese Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) — among the worst performers since Trump&#8217;s election — will be moved to the S&amp;P SmallCap 600.
Price Action: Palantir closed at $84.90 on Friday, up 5.52% for the day, before dipping 0.09% to $84.82 in after-hours trading. Year to date, the stock has gained 12.92%, while it has surged 234.92% over the past year. Although the stock is down 38% from its all-time high of $124.62 reached on Feb. 18, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44212672/jamie-dimon-cashed-out-234-million-in-jpmorgan-stock-warren-buffett-stockpiled-334-billion-in-cash-weeks-later-markets-crashed-coincidence">Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

DASH

PLTR

Palantir Joins S&P 100 After AI-Driven Rally, Stock Surges Almost 60% Since Trump Victory

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 18.43% on an annualized basis producing an average annual return of 26.62%. Currently, Intuitive Surgical has a market capitalization of $200.68 billion. 
Buying $1000 In ISRG: If an investor had bought $1000 of ISRG stock 20 years ago, it would be worth $117,740.76 today based on a price of $562.67 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741118412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

NXST

TOST

CNBC Halftime Report Final Trades: Toast, Nexstar Media Group, Salesforce, Intuitive Surgical

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 10 years by 15.24% on an annualized basis producing an average annual return of 26.48%. Currently, Intuitive Surgical has a market capitalization of $212.41 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 10 years ago, it would be worth $1,045.11 today based on a price of $595.55 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739568608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $182,470, and 6 are calls, for a total amount of $760,472.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $540.0 to $660.0 for Intuitive Surgical over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 163.12 with a total volume of 549.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $540.0 to $660.0 over the last 30 days.
<h3>Intuitive Surgical Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739560529_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$32.1</td>
<td>$28.9</td>
<td>$28.9</td>
<td>$590.00</td>
<td>$289.0K</td>
<td align="right">158</td>
<td align="right">100</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$53.7</td>
<td>$52.8</td>
<td>$53.7</td>
<td>$590.00</td>
<td>$268.5K</td>
<td align="right">72</td>
<td align="right">54</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$33.8</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$540.00</td>
<td>$155.0K</td>
<td align="right">169</td>
<td align="right">47</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$96.0</td>
<td>$92.9</td>
<td>$92.9</td>
<td>$660.00</td>
<td>$120.7K</td>
<td align="right">81</td>
<td align="right">24</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$150.2</td>
<td>$145.3</td>
<td>$148.36</td>
<td>$550.00</td>
<td>$29.6K</td>
<td align="right">24</td>
<td align="right">2</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>With a volume of 637,780, the price of ISRG is up 0.55% at $594.63. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>Professional Analyst Ratings for Intuitive Surgical</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $682.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on Intuitive Surgical, maintaining a target price of $666. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Intuitive Surgical, targeting a price of $675. 
&#x2A; Consistent in their evaluation, an analyst from Raymond James keeps a Outperform rating on Intuitive Surgical with a target price of $688. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $711. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Overweight with a new price target of $670.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Surgical options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Intuitive Surgical's Latest Options Trends

Investors with a lot of money to spend have taken a bullish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 45% bullish and 36%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $326,170, and 8 are calls, for a total amount of $573,816.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $335.0 to $620.0 for Intuitive Surgical during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $335.0 to $620.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739388630_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$173.5</td>
<td>$167.5</td>
<td>$170.2</td>
<td>$460.00</td>
<td>$238.2K</td>
<td align="right">0</td>
<td align="right">57</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$43.5</td>
<td>$41.4</td>
<td>$42.0</td>
<td>$500.00</td>
<td>$210.0K</td>
<td align="right">5</td>
<td align="right">51</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$98.7</td>
<td>$94.6</td>
<td>$98.8</td>
<td>$590.00</td>
<td>$98.7K</td>
<td align="right">37</td>
<td align="right">9</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$24.5</td>
<td>$22.1</td>
<td>$23.8</td>
<td>$575.00</td>
<td>$95.2K</td>
<td align="right">227</td>
<td align="right">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$44.0</td>
<td>$43.0</td>
<td>$43.0</td>
<td>$500.00</td>
<td>$86.0K</td>
<td align="right">5</td>
<td align="right">91</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Intuitive Surgical's Current Market Status</h3>
<ul>
<li>Trading volume stands at 489,081, with ISRG's price down by -0.45%, positioned at $589.0.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $681.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $670. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $666. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $711. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Intuitive Surgical, which currently sits at a price target of $687. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Intuitive Surgical with a target price of $675. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Intuitive Surgical, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Intuitive Surgical

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 10 years by 15.36% on an annualized basis producing an average annual return of 26.62%. Currently, Intuitive Surgical has a market capitalization of $209.84 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 10 years ago, it would be worth $1,056.33 today based on a price of $588.37 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738767608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 10 Years

Investors with a lot of money to spend have taken a bearish stance on Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ISRG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Intuitive Surgical.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 47%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $85,945, and 15 are calls, for a total amount of $773,230.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $450.0 and $670.0 for Intuitive Surgical, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $450.0 to $670.0 in the last 30 days. 
<h3>Intuitive Surgical Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738602936_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$40.2</td>
<td>$37.8</td>
<td>$38.9</td>
<td>$565.00</td>
<td>$155.6K</td>
<td align="right">38</td>
<td align="right">41</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$55.2</td>
<td>$54.5</td>
<td>$54.5</td>
<td>$560.00</td>
<td>$76.3K</td>
<td align="right">175</td>
<td align="right">14</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$34.2</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$565.00</td>
<td>$67.4K</td>
<td align="right">38</td>
<td align="right">20</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$34.0</td>
<td>$32.7</td>
<td>$32.7</td>
<td>$565.00</td>
<td>$65.4K</td>
<td align="right">38</td>
<td align="right">41</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$29.7</td>
<td>$27.5</td>
<td>$28.6</td>
<td>$570.00</td>
<td>$57.2K</td>
<td align="right">381</td>
<td align="right">70</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
In light of the recent options history for Intuitive Surgical, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>Currently trading with a volume of 820,079, the ISRG's price is up by 1.69%, now at $581.55. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 73 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $684.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Intuitive Surgical, targeting a price of $687. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Intuitive Surgical, targeting a price of $711. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $670. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $666. 
&#x2A; An analyst from Raymond James has decided to maintain their Outperform rating on Intuitive Surgical, which currently sits at a price target of $688. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Rumors

Watching Intuitive Surgical; Shares See Volume, Traders Circulate Unconfirmed Rumor Co Wins Ongoing Repair Company Trail; $7B Hospital Class Action Remains Pending

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$25.00</td>
<td>$35.5K</td>
<td>6.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$150.00</td>
<td>$66.4K</td>
<td>7.2K</td>
<td>1.7K</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$55.00</td>
<td>$42.0K</td>
<td>3.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$27.50</td>
<td>$109.6K</td>
<td>31.8K</td>
<td>1.1K</td>
</tr>
<tr>
<td>INMB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.00</td>
<td>$25.5K</td>
<td>2.1K</td>
<td>486</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$590.00</td>
<td>$45.0K</td>
<td>291</td>
<td>275</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$30.00</td>
<td>$34.0K</td>
<td>567</td>
<td>261</td>
</tr>
<tr>
<td>SWTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$35.00</td>
<td>$25.4K</td>
<td>511</td>
<td>220</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$62.50</td>
<td>$44.9K</td>
<td>137</td>
<td>189</td>
</tr>
<tr>
<td>BAX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$35.00</td>
<td>$36.8K</td>
<td>68</td>
<td>160</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TEVA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>), we observe a call option trade with bearish sentiment. It expires in 354 day(s) on January 16, 2026. Parties traded 163 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $35.5K, with a price of $218.0 per contract. There were 6058 open contracts at this strike prior to today, and today 2167 contract(s) were bought and sold. 
• For JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we notice a call option sweep that happens to be bearish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 200 contract(s) at a $150.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $66.4K, with a price of $336.0 per contract. There were 7225 open contracts at this strike prior to today, and today 1758 contract(s) were bought and sold. 
• Regarding CVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), we observe a put option trade with bearish sentiment. It expires in 25 day(s) on February 21, 2025. Parties traded 200 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $42.0K, with a price of $210.0 per contract. There were 3069 open contracts at this strike prior to today, and today 1262 contract(s) were bought and sold. 
• For PFE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), we notice a call option sweep that happens to be bearish, expiring in 354 day(s) on January 16, 2026. This event was a transfer of 522 contract(s) at a $27.50 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $109.6K, with a price of $210.0 per contract. There were 31825 open contracts at this strike prior to today, and today 1191 contract(s) were bought and sold. 
• For INMB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>), we notice a call option sweep that happens to be bullish, expiring in 235 day(s) on September 19, 2025. This event was a transfer of 75 contract(s) at a $10.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $25.5K, with a price of $340.0 per contract. There were 2116 open contracts at this strike prior to today, and today 486 contract(s) were bought and sold. 
• Regarding ISRG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on January 31, 2025. Parties traded 200 contract(s) at a $590.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $45.0K, with a price of $225.0 per contract. There were 291 open contracts at this strike prior to today, and today 275 contract(s) were bought and sold. 
• For VKTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), we notice a put option sweep that happens to be bullish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 252 contract(s) at a $30.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $34.0K, with a price of $135.0 per contract. There were 567 open contracts at this strike prior to today, and today 261 contract(s) were bought and sold. 
• For SWTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>), we notice a call option trade that happens to be bearish, expiring in 25 day(s) on February 21, 2025. This event was a transfer of 50 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $510.0 per contract. There were 511 open contracts at this strike prior to today, and today 220 contract(s) were bought and sold. 
• For BMY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), we notice a put option sweep that happens to be bearish, expiring in 53 day(s) on March 21, 2025. This event was a transfer of 156 contract(s) at a $62.50 strike. This particular put needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $44.9K, with a price of $288.0 per contract. There were 137 open contracts at this strike prior to today, and today 189 contract(s) were bought and sold. 
• For BAX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>), we notice a call option trade that happens to be bullish, expiring in 718 day(s) on January 15, 2027. This event was a transfer of 80 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $36.8K, with a price of $460.0 per contract. There were 68 open contracts at this strike prior to today, and today 160 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INMB

SWTX

TEVA

VKTX

10 Health Care Stocks With Whale Alerts In Today's Session

Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
What Happened: Huberty expressed that we are currently at a &#8220;tipping point&#8221; for AI adoption. She underscored that businesses utilizing AI to boost their profits are on the verge of reaping considerable benefits.
Speaking <a href="https://www.businessinsider.com/ai-adopters-stocks-to-buy-beneficiaries-pricing-power-morgan-stanley-2025-1#home-depot-1">with</a> Business Insider earlier this month, Huberty pointed out that businesses with strong pricing power, those capable of maintaining or increasing their prices due to high demand, will witness the most significant impact on their profits. 
&#8220;Pricing power will allow the&nbsp;companies to retain the productivity&nbsp;that they experience on the&nbsp;back of these investments and&nbsp;not have to pass that&nbsp;on to the customer,&#8221; she elaborated.
Also Read: <a href="https://www.benzinga.com/markets/25/01/43216975/fund-manager-stanley-druckenmiller-delivers-blunt-take-on-markets-after-trumps-return-in-terms-of-markets-i-would-say-its-complicated">Fund Manager Stanley Druckenmiller Delivers Blunt Take On Markets After Trump&#8217;s Return: &#8216;In Terms of Markets, I Would Say It&#8217;s Complicated&#8217;</a>
Huberty referred&nbsp;to a list of stocks&nbsp;her team assembled in client&nbsp;note. The stocks, all AI adopters with high pricing power, have&nbsp;market caps over $20 billion.&nbsp;The list comprises&nbsp;The Home Depot, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>),&nbsp;Thermo Fisher Scientific Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), and&nbsp;Intuitive Surgical, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>), MercadoLibre Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), Marriott International Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>), Hilton Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>), Schlumberger NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>), Johnson Controls International PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>), Axon Enterprise Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>), Coupang Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>), Baker Hughes Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Experian PLC, Delta Air Lines Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), IDEXX Laboratories Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>), United Airlines Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UA#NASDAQ">UA</a>), Halliburton Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>), among others.
Why It Matters: The adoption of AI has been a hot topic in recent years, with many industries recognizing its potential to transform business operations and drive profitability. 
Huberty&#8217;s identification of these 20 stocks underscores the growing importance of AI in the business landscape. Companies that successfully leverage AI technologies stand to gain a competitive edge, particularly those with strong pricing power. 
This development could signal a shift in investment strategies, with investors potentially looking to companies with strong AI adoption as promising opportunities.
Read Next
<a href="https://www.benzinga.com/markets/25/01/43217038/aoc-says-democrats-in-congress-are-doing-insider-trading-people-think-that-everyday-people-are-stupid">AOC Says Democrats in Congress Are Doing Insider Trading: &#8216;People Think That Everyday People Are Stupid&#8217;</a>
Image: Shutterstock

Commodities

AXON

CPNG

IDXX

MELI

PCAR

SPOT

Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass

Wall Street paused for a breather on Friday, with the S&amp;P 500 index hovering around the flatline at midday trading in New York after a five-day rally that pushed the market to fresh record highs this week. Meanwhile, investor attention shifted to <a href="https://www.benzinga.com/markets/forex">forex and gold markets.</a>
The greenback is experiencing its worst weekly performance since July 2023, as President Donald Trump refrained from imposing new tariffs during his first week and escalated pressure on the Federal Reserve, urging the central bank to lower interest rates. The U.S. dollar index – tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – dropped 0.7% on Friday, extending its weekly decline to 1.7%.
Adding to the dollar's downward momentum, the Bank of Japan raised interest rates by 25 basis points to 0.5%, the highest level since 2008, in a move that broadly met expectations.
Gold capitalized on the dollar's weakness and rising tensions between the president and the central bank, marking another week of strong gains and approaching all-time highs. The bullion, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), was trading at $2,777 per ounce.
On the macro front, S&amp;P Global reported a slowdown in private sector growth in January, as the services sector faced an unexpected setback, despite manufacturing expanding for the first<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43195427/us-services-growth-slows-manufacturing-finally-expands-in-january-inflation-was-broad-based-expert-warns"> time in seven months.</a>
A warning came from the University of Michigan's consumer survey, which downwardly revised the January consumer confidence indicator and pointed to increasing trends of households making purchases in advance to avoid potential price hikes <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43197024/consumer-confidence-declines-as-buying-in-advance-trends-grow">linked to tariffs.</a>
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.5% following Trump's executive order signed on Thursday, aimed at strengthening U.S. leadership in digital assets. 
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,314.96</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,119.65</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,541.76</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,861.02</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) eased 0.1% to $608.89.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $444.96.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slipped 0.4% to $530.73.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $229.40.</li>
<li>The&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 0.9%; the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.4%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) fell 2.4% after reporting fourth-quarter results. </li>
<li>Other stocks moving on quarterly results were Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), up 1.3%, NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), up 4%, HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), down 3.2%, First Citizens BancShares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>), up 3.1%, Ericsson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIC#NASDAQ">ERIC</a>), down 14.3%, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), down 3.6%, Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), down 7.1%, and CSX Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), down 2.8%. </li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) soared 8.1% after new weight loss drug amycretin showed strong trial results. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43198272/us-stocks-hit-dot-com-era-valuations-vs-bonds-why-some-experts-remain-bullish">US Stocks Hit Dot-Com Era Valuations Vs. Bonds: Why Some Experts Remain Bullish</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Forex

Econ #s

Economics

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ERIC

FCNCA

PowerShares DB US Dollar Index Bullish Fund

Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?

Press Releases

Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

Management

Intuitive Announces Executive Leadership Changes to Support Continued Global Growth

Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal

Intuitive Announces Fourth Quarter Earnings

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education

Astera Labs Appoints Dr. Craig Barratt to Board of Directors

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Peer-Reviewed Studies on Intuitive's Force Feedback Technology Demonstrate its Potential to Reduce Force on Tissue and Enhance Surgeon Performance

ALAB

AMBC

BBWI

CLSK

FLGT

FRPT

GDOT

GPRE

HAIN

HIMS

KTOS

MATV

MBOT

NEOG

SATS

SPGI

Abbott Laboratories

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Integer Holdings Corporation Common Stock

Integer Holdings

Masimo

Medtronic

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

Zimmer Biomet Holdings, Inc. Common Stock

Comments

Intuitive Surgical

ニュース

パートナーシップ

ベンジンガ・グローバル